Simplex Trading’s LYRA THERAPEUTICS INC LYRA Stock Holding History

Simplex Trading’s Portfolio LYRA Stock Details LYRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-60	Closed	-$15K	–	9419
2023 Q4	$15K	Buy	+60	New	+$10.9K	﹤0.01%	7142

Other funds holding LYRA

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Simplex Trading's LYRA Position: Q2 2025 in Review

Simplex Trading sold out of LYRA THERAPEUTICS INC (LYRA) in Q2 2025, closing a stake of 26 shares.

Simplex Trading first reported a position in LYRA in Q2 2023 and held it in 7 quarters. The position peaked at $35K in Q2 2024. 30 funds tracked by Wall St. Rank hold LYRA as of Q2 2025.

Simplex Trading reported no remaining LYRA THERAPEUTICS INC position as of Q2 2025 after selling out during the quarter.
Simplex Trading sold 26 LYRA THERAPEUTICS INC shares in Q2 2025.
Simplex Trading first reported a position in LYRA THERAPEUTICS INC in Q2 2023 and held it in 7 quarters.
Simplex Trading's LYRA THERAPEUTICS INC position peaked at $35K in Q2 2024.
30 funds tracked by Wall St. Rank held LYRA THERAPEUTICS INC as of Q2 2025.

Based on Simplex Trading's 13F filing for Q2 2025, filed 5 Aug 2025.